ALIBABA-GROUP-SERVICES
30.7.2020 10:02:13 CEST | Business Wire | Press release
Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, has supported Paris 2024 to its latest engagement initiative “Le Club Paris 2024” on club.paris2024.org . The interactive website is the digital gateway for those who are interested in the Olympic Games. It will also enable the sports fans to interact and become more engaged through the various community activities Le Club Paris 2024 has to offer.
As the Worldwide Olympic Partner and official cloud service provider, Alibaba Cloud has been supporting Paris 2024’s digital infrastructure since the organization’s inception, including hosting the official website Paris2024.org. Alibaba Cloud’s leading computing capabilities together with its wide range of service portfolios, have been pivotal for Paris 2024 to deliver online projects rapidly while meeting the stringent requirement on website hosting and network security.
To support the various functions of the Le Club Paris 2024 website, Alibaba Cloud deploys its services, featuring powerful devOps to ensure the digital platform is easily managed with minimal interruption even when receiving an influx of requests, such as during the kick off of an online campaign when heavy online traffic is expected. With strong technical capabilities, Alibaba Cloud provides smooth user experience for the various interactive activities via its website, making the Olympics experience an exciting online engagement.
“Four years from the Paris Olympics and Paralympics Games, we have launched ‘Le Club Paris 2024’ , open to everyone with one watch word: Enter the Games. Your turn to play. Our ambition is to offer to everyone the opportunity to engage themselves by our side and to fully live the experience. We are pleased to work with Alibaba Cloud on this mission, and by leveraging its cloud computing and digital transformation expertise, we can give everyone a unique experience as part of their own Paris 2024 journey,” said Romain Lachens, Engagement Director, Paris 2024.
Chris Tung, Alibaba Group Chief Marketing Office, said, “As a World Olympic Partner since PyeongChang 2018, we have been working closely with the IOC and local organizing committees to create a more inclusive, and the next-generation Olympics starting from Tokyo 2020 to Beijing 2022, Paris 2024 and beyond. We are confident that our cloud technology and e-commerce innovations can help contribute to take the Games to new levels.”
“We are very excited to support Paris 2024 with its digital transformation journey, and to bring our leading technology capabilities to digitalize the Olympic Games,” said Selina Yuan, President of International Business, Alibaba Cloud Intelligence. “Together with Paris 2024, we are confident that the Olympic fans will be able to experience the excitement of the Games, and to spread the spirit of the Games to both online and offline communities.”
About Alibaba Cloud
Established in 2009, Alibaba Cloud (alibabacloud.com ), the digital technology and intelligence backbone of Alibaba Group, is among the world’s top three IaaS providers, according to Gartner. It is also the largest provider of public cloud services in China, according to IDC. Alibaba Cloud provides a comprehensive suite of cloud computing services to businesses worldwide, including merchants doing business on Alibaba Group marketplaces, start-ups, corporations and public services. Alibaba Cloud is the official Cloud Services Partner of the International Olympic Committee.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200730005039/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom